Search

Author/Creator Gelb, Arnold B.

1. Avelumab (anti–PD-L1) as first-line switch-maintenance or second-line therapy in patients with advanced gastric or gastroesophageal junction cancer: phase 1b results from the JAVELIN Solid Tumor trial. Issue 1 (4th February 2019)

Authors:
Chung, Hyun Cheol; Arkenau, Hendrik-Tobias; Lee, Jeeyun; Rha, Sun Young; Oh, Do-Youn; Wyrwicz, Lucjan; Kang, Yoon-Koo; Lee, Keun-Wook; Infante, Jeffrey R.; Lee, Sung Sook; Kemeny, Margaret; Keilholz, Ulrich; Melichar, Bohuslav; Mita, Alain; Plummer, Ruth; Smith, Denis; Gelb, Arnold B.; Xiong, Hui...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 7:Issue 1(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. PH20 is not expressed in murine CNS and oligodendrocyte precursor cells. Issue 3 (23rd February 2017)

Authors:
Marella, Mathieu; Ouyang, Joe; Zombeck, Jonathan; Zhao, Chunmei; Huang, Lei; Connor, Robert J.; Phan, Kim B.; Jorge, Michael C.; Printz, Marie A.; Paladini, Rudolph D.; Gelb, Arnold B.; Huang, Zhongdong; Frost, Gregory I.; Sugarman, Barry J.; Steinman, Lawrence; Wei, Ge; Shepard, H. Michael; Mane...
Journal:
Annals of clinical and translational neurology
Issue:
Volume 4:Issue 3(2017)
Page Start:
191
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗